Old Web
English
Sign In
Acemap
>
Paper
>
A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
A Phase 2b Study of Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)
2019
Nagesh Kalakonda
Federica Cavallo
George A. Follows
Andre Goy
Joost S.P. Vermaat
Olivier Casasnovas
Orly Lavee
Marie Maerevoet
Josée M. Zijlstra
Sameer Bakhshi
Reda Bouabdallah
Sylvain Choquet
Ronit Gurion
Brian T. Hill
Ulrich Jaeger
Juan-Manuel Sancho
Michael Schuster
Catherine Thieblemont
Fátima Cruz
Miklós Egyed
Sourav Mishra
Fritz Offner
Theodoros P. Vassilakopoulos
Krzysztof Warzocha
Daniel McCarthy
Xiwen Ma
Kelly Corona
Jean-Richard Saint-Martin
Anita Joshi
Jatin P. Shah
Eric Van Den Neste
Miguel Canales
Keywords:
Refractory
Diffuse large B-cell lymphoma
Pathology
Medicine
Cancer research
in patient
relapsed refractory
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]